共 51 条
[1]
Pfeffer MA(2009)A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2019-2032
[2]
Burdmann EA(2012)Treatment of iron deficiency in predialysis state by low molecular weight iron dextran high doses intravenously Nephrol Ther 8 41-46
[3]
Chen CY(2002)Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury Am J Kidney Dis 40 90-103
[4]
Fievet P(2012)Obesity and iron deficiency in chronic kidney disease: the putative role of hepcidin Nephrol Dial Transpl 27 50-57
[5]
Coppin M(2010)Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents Nephrol Dial Transpl 25 3996-4002
[6]
Brazier F(2012)Serum albumin as predictor of nutritional status in patients with ESRD Clin J Am Soc Nephrol 7 1446-1453
[7]
Lefevre M(2012)Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study Nephrol Dial Transpl 27 1076-1083
[8]
Stephan R(2009)Hepcidin––a potential novel biomarker for iron status in chronic kidney disease Clin J Am Soc Nephrol 4 1051-1056
[9]
Demontis R(2008)SELDI–TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard Proteome Sci 6 28-853
[10]
Zager RA(2010)Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate Nephrol Dial Transpl 25 848-981